Anthem Blue Cross (HMO, PPO, EPO) |
Braftovi (encorafenib) |
Drugs for Cancer : Drugs for Cancer |
- Neutropenia:
Age Requirement: >= 18
Duration: 6 Month(s)
Medical Test Required: No
Reauthorization Required: Yes
Duration of Reauthorization: = 6 month(s)
Supporting Documentation Requirements: 1 of Chart Notes;Lab Tests
Dosing Limit Defined In Policy: 2 of 6mg;Per chemotherapy cycle
Billing Note(s): HCPCS Code/ JCode Required
Documented Diagnosis: Yes
Criteria includes risk factor for developing FN: No
- Prior Authorization: Diabetic Medical Supplies:
Documented Diagnosis: Yes
Duration: 1 plan year
Reauthorization Required: Yes
|